Norges Bank’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$489K Hold
2024
Q3
$836K Hold
2024
Q2
$414K Hold
2024
Q1
$792K Hold
2023
Q4
$1.42M Hold
2023
Q3
$1.85M Hold
2023
Q2
$4.07M Hold
2023
Q1
$5.19M Hold
2022
Q4
$2.97M Buy